HIV counseling and testing of pregnant women in sub-Saharan Africa - Experiences from a study on prevention of mother-to-child HIV-1 transmission in Dar es Salaam, Tanzania

被引:0
作者
Kilewo, C
Massawe, A
Lyamuya, E
Semali, I
Kalokola, F
Urassa, E
Giattas, M
Temu, F
Karlsson, K
Mhalu, F
Biberfeld, G [1 ]
机构
[1] Karolinska Inst, Swedish Inst Infect Dis Control & Microbiol, SE-17182 Solna, Sweden
[2] Karolinska Inst, Tumor Biol Ctr, SE-17182 Solna, Sweden
[3] Muhimbili Univ, Coll Hlth Sci, Dept Obstet & Gynaecol, Dar Es Salaam, Tanzania
[4] Muhimbili Univ, Coll Hlth Sci, Dept Pediat & Child Hlth, Dar Es Salaam, Tanzania
[5] Muhimbili Univ, Coll Hlth Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania
[6] Muhimbili Univ, Coll Hlth Sci, Dept Epidemiol & Biostat, Dar Es Salaam, Tanzania
关键词
HIV-1; counseling and testing; pregnant women; Arica;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The aim of this study was to determine the acceptability of HIV counseling and testing and participation in a mother-to-child HIV-1 transmission intervention study using antiretroviral therapy in Dar es Salaam, Tanzania, one of the sites for the Joint United Nations Program on AIDS (UNAIDS) multicenter Petra trial. HIV testing was offered to all pregnant women who visited three prenatal clinics in Dar es Salaam before 34 weeks' gestation. Group or individual pretest counseling was performed by trained midwives. Laboratory diagnosis of HIV infection was based on two sequential anti-HIV enzyme-linked immunosorbent assays. Posttest counseling was given 2 weeks later to women who wished to know their HIV status. HIV testing was offered to a total of 10,010 pregnant women from June 1996 to May 1998, of hom 76.4% (7647 of 10,010) agreed to be tested. The prevalence of HIV-1 infection was 13.7% (1050 of 7647). Overall, 68.1% (5205 of 7647) returned for their results. Of the HIV-1-seropositive respondents, 27.4% (288 of 1050) a.-reed to participate in the Petra trial after fulfilling the eligibility criteria. Only 16.7% (48 of 288) of the enrolled women disclosed their positive HIV serostatus to their sexual partners. The main reasons for not disclosing the HIV serostatus were fear of stigma and divorce. Sixty percent (29 of 48) of the informed sex partners agreed to be tested for HIV and 69% (20 of 29) tested HIV seropositive. Pregnancy recurrence rate was 4.4 per 100 women years (18 pregnancies during 408 women years of follow-up) with 10 of 18 (55.6%) women not wanting to carry the pregnancy to term. In conclusion, this information is useful in planning intervention programs for prevention of mother-to-child HIV-1 transmission and it shows that improvements are required in counseling.
引用
收藏
页码:458 / 462
页数:5
相关论文
共 19 条
[1]   The prevalence and incidence of HIV-1 infection and syphilis in a cohort of police officers in Dar es Salaam, Tanzania:: a potential population for HIV vaccine trials [J].
Bakari, M ;
Lyamuya, E ;
Mugusi, F ;
Aris, E ;
Chale, S ;
Magao, P ;
Jossiah, R ;
Janabi, M ;
Swai, A ;
Pallangyo, N ;
Sandström, E ;
Mhalu, F ;
Biberfeld, G ;
Pallangyo, K .
AIDS, 2000, 14 (03) :313-320
[2]   Acceptability of voluntary HIV testing by pregnant women in developing countries: an international survey [J].
Cartoux, M ;
Meda, N ;
Van de Perre, P ;
Newell, ML ;
de Vincenzi, I ;
Dabis, F .
AIDS, 1998, 12 (18) :2489-2493
[3]   Evaluation of 2 techniques of HIV pre-test counselling for pregnant women in West Africa [J].
Cartoux, M ;
Sombié, I ;
Van de Perre, P ;
Meda, N ;
Tiendrébéogo, S ;
Dabis, F .
INTERNATIONAL JOURNAL OF STD & AIDS, 1999, 10 (03) :199-201
[4]   Attitude of pregnant women towards HIV testing in Abidjan, Cote d'Ivoire and Bobo-Dioulasso, Burkina Faso [J].
Cartoux, M ;
Msellati, P ;
Meda, N ;
Welffens-Ekra, C ;
Mandelbrot, L ;
Leroy, V ;
Van de Perre, P ;
Dabis, F .
AIDS, 1998, 12 (17) :2337-2344
[5]   REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT [J].
CONNOR, EM ;
SPERLING, RS ;
GELBER, R ;
KISELEV, P ;
SCOTT, G ;
OSULLIVAN, MJ ;
VANDYKE, R ;
BEY, M ;
SHEARER, W ;
JACOBSON, RL ;
JIMENEZ, E ;
ONEILL, E ;
BAZIN, B ;
DELFRAISSY, JF ;
CULNANE, M ;
COOMBS, R ;
ELKINS, M ;
MOYE, J ;
STRATTON, P ;
BALSLEY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) :1173-1180
[6]   6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'Ivoire and Burkina Faso:: a double-blind placebo-controlled multicentre trial [J].
Dabis, F ;
Msellati, P ;
Meda, N ;
Welffens-Ekra, C ;
You, B ;
Manigart, O ;
Leroy, V ;
Simonon, A ;
Cartoux, M ;
Combe, P ;
Ouangré, A ;
Ramon, R ;
Ky-Zerbo, O ;
Montcho, C ;
Salamon, R ;
Rouzioux, C ;
Van de Perre, P ;
Mandelbrot, L .
LANCET, 1999, 353 (9155) :786-792
[7]  
Gibb DM, 1999, AIDS, V13, pS93
[8]   Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVMET 012 randomised trial [J].
Guay, LA ;
Musoke, P ;
Fleming, T ;
Bagenda, D ;
Allen, M ;
Nakabiito, C ;
Sherman, J ;
Bakaki, P ;
Ducar, C ;
Deseyve, M ;
Emel, L ;
Mirochnick, M ;
Fowler, MG ;
Mofenson, L ;
Miotti, P ;
Dransfield, K ;
Bray, D ;
Mmiro, F ;
Jackson, JB .
LANCET, 1999, 354 (9181) :795-802
[9]   A cohort study of factors associated with failure to return for HIV post-test counselling in pregnant women: Kigali, Rwanda, 1992-1993 [J].
Ladner, J ;
Leroy, V ;
Msellati, P ;
Nyiraziraje, M ;
DeClerq, A ;
VandePerre, P ;
Dabis, F ;
Ntawuruhunga, J ;
Cyamana, A ;
Mudaheranwa, M ;
Munyangabe, C ;
Ntezayabo, B ;
Ukulikiyimfura, C ;
Zilimwagabo, C ;
Bogaerts, J ;
Karita, E ;
Simonon, A ;
Bazubagira, A ;
Hitimana, DG ;
Murayire, E ;
Nsengumuremyi, F ;
Nyandwi, C ;
VanGoethem, C ;
Gazille, C ;
Salamon, R .
AIDS, 1996, 10 (01) :69-75
[10]   Trends in perinatal transmission of HIV/AIDS in the United States [J].
Lindegren, ML ;
Byers, RH ;
Thomas, P ;
Davis, SF ;
Caldwell, B ;
Rogers, M ;
Gwinn, M ;
Ward, JW ;
Fleming, PL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (06) :531-538